Daewoong Pharmaceutical, 22.73% ↑ on Botox (Botulinum Toxin) Theme Uptrend
On the 5th, the Botox (Botulinum Toxin) theme showed strength by rising 4.00% compared to the previous day, while Daewoong Pharmaceutical, a related stock drawing attention, surged 22.73% compared to the previous day. Daewoong Pharmaceutical is known as a leading pharmaceutical company manufacturing and selling medicines such as Urusa and Albis.
[Graph] Major stock price changes in the Botox (Botulinum Toxin) theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Daewoong Pharmaceutical’s quant financial score is 39.92 points, showing higher growth and stability scores than the average of other stocks related to Botox (Botulinum Toxin), but its quant financial ranking was only 5th out of 8 stocks. On the other hand, Huons Global ranked 1st in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.
[Table] Top stocks by financial score within the theme
※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "While Others Rest, Nearly 3 Million May Work Substitute Public Holidays Without Extra Pay"
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.